Published in J Immunol on December 01, 1988
Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med (1994) 1.17
Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver. Immunology (1994) 1.01
Roles of tumor necrosis factor and macrophages in lipopolysaccharide-induced accumulation of neutrophils in cutaneous air pouches. Infect Immun (1990) 0.91
A protective role of platelet-activating factor in murine candidiasis. Infect Immun (1997) 0.87
Cytokine gene regulation by PGE(2), LTB(4) and PAF. Mediators Inflamm (1992) 0.86
Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction. J Exp Med (2003) 0.86
Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor. Clin Exp Immunol (1995) 0.85
Phospholipids coupled to a carrier induce IgG antibody that blocks tumour necrosis factor induction by toxic malaria antigens. Immunology (1993) 0.85
Platelet activating factor contributes to vascular leak in acute dengue infection. PLoS Negl Trop Dis (2015) 0.84
IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE). Clin Exp Immunol (2000) 0.84
Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. Immunology (1997) 0.83
Pentosan polysulfate inhibits atherosclerosis in Watanabe heritable hyperlipidemic rabbits: differential modulation of metalloproteinase-2 and -9. Lab Invest (2011) 0.82
Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor. Immunology (1992) 0.82
Up-regulation of tumour necrosis factor-alpha receptors on monocytes by desferrioxamine. Clin Exp Immunol (1992) 0.81
Relationship between interleukin-1 beta and platelet-activating factor in the pathogenesis of acute immune complex alveolitis in the rat. Am J Pathol (1992) 0.81
Leukotriene B4 and platelet-activating factor in human skin. Arch Dermatol Res (1992) 0.80
Increased expression and occupancy of receptors for tumour necrosis factor on blood monocytes from tuberculosis patients. Clin Exp Immunol (1993) 0.80
IL-1 beta and IL-6 stimulate the production of platelet-activating factor (PAF) by cultured rabbit synovial cells. Clin Exp Immunol (1995) 0.79
Pathogenesis of vascular leak in dengue virus infection. Immunology (2017) 0.75
Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: regulation by desferrioxamine. Immunology (1993) 0.75
Tumor necrosis factor and platelet activating factor in stool during salmonellosis. Gut (1994) 0.75
Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature (1986) 4.06
A unique set of polypeptides is induced by gamma interferon in addition to those induced in common with alpha and beta interferons. Nature (1983) 2.68
Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem (1995) 2.38
Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens. Cell Immunol (1974) 1.85
PPD-stimulated interferon: in vitro macrophage-lymphocyte interaction in the production of a mediator of cellular immunity. Cell Immunol (1971) 1.75
Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination. Proc Natl Acad Sci U S A (1972) 1.73
Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. Proc Natl Acad Sci U S A (1995) 1.45
An appraisal of an autoradiographic technique for enumeration of antibody containing cells in response to Salmonella somatic polysaccharide. Int Arch Allergy Appl Immunol (1967) 1.43
Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages. Cell Immunol (1980) 1.32
Mitogen and antigen induction of interferon in vitro and in vivo. Tex Rep Biol Med (1977) 1.19
Genes coding for sensitivity to interferon (IfRec) and soluble superoxide dismutase (SOD-1) are linked in mouse and man and map to mouse chromosome 16. Proc Natl Acad Sci U S A (1980) 1.13
Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1. J Immunol (1991) 1.13
Evaluation of T lymphocyte effector function in immunodeficiency diseases: abnormality in mitogen-stimulated interferon in patients with selective IgA deficiency. J Immunol (1974) 1.13
Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ (1998) 1.13
Localization fo the gene AVG for the antiviral expression of immune and classical interferon to the distal portion of the long arm of chromosome 21. J Infect Dis (1976) 1.11
Protocols to establish genotype-phenotype correlations in Down syndrome. Am J Hum Genet (1991) 1.08
Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor. J Immunol (1988) 1.08
Mouse trisomy 16 as an animal model of human trisomy 21 (Down syndrome): production of viable trisomy 16 diploid mouse chimeras. Dev Biol (1984) 1.07
Mass spectrometric and Edman sequencing of lipocortin I isolated by two-dimensional SDS/PAGE of human melanoma lysates. Proc Natl Acad Sci U S A (1993) 1.03
Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon-alpha receptor. Biochem Biophys Res Commun (1982) 1.02
Ichthyosis and neutral lipid storage disease. Am J Med Genet (1985) 1.02
Mouse trisomy 16: an animal model of human trisomy 21 (Down syndrome). Ann N Y Acad Sci (1985) 1.02
Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21). J Immunol (1992) 1.02
Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique. Ann N Y Acad Sci (1980) 1.00
Structure-activity studies of interleukin-2. Science (1986) 1.00
Immobilized pH gradient two-dimensional gel electrophoresis and mass spectrometric identification of cytokine-regulated proteins in ME-180 cervical carcinoma cells. Electrophoresis (1997) 0.98
Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). J Immunol (1986) 0.96
Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect ot interferon. Cell Immunol (1980) 0.96
The in vivo induction of mouse lymphocyte transformation by phytohemagglutinin. J Immunol (1968) 0.95
The chromosomal location of mouse interferon alpha genes. EMBO J (1984) 0.93
Human T-lymphocyte subset production of immune (gamma) interferon. J Clin Immunol (1981) 0.93
Interferon-gamma: success, structure and speculation. Nature (1982) 0.92
Functional implications of gene dosage effects in trisomy 21. Hum Genet Suppl (1981) 0.92
T-lymphocyte function and sensitivity to interferon in trisomy 21. Cell Immunol (1980) 0.92
The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. Cytogenet Cell Genet (1986) 0.90
Coordinated induction of autocrine tumor necrosis factor and interleukin 1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity. Cancer Res (1990) 0.90
Trisomy 21: mechanisms and models. Ann N Y Acad Sci (1982) 0.90
Interferon induction of (2'-5') oligoisoadenylate synthetase in diploid and trisomy 21 human fibroblasts: relation to dosage of the interferon receptor gene (IRFC). Hum Genet (1983) 0.90
Induction of leucine aminopeptidase by interferon-gamma. Identification by protein microsequencing after purification by preparative two-dimensional gel electrophoresis. J Biol Chem (1992) 0.89
Monocyte-derived macrophages: an in vitro system for studying hereditary lysosomal storage diseases. Pediatr Res (1978) 0.89
The antiproliferative effects of interferon on murine embryonic cells. Proc Soc Exp Biol Med (1979) 0.87
Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus. Clin Immunol Immunopathol (1992) 0.86
Effect of Corynebacterium parvum on human T-lymphocyte interferon production and T-lymphocyte proliferation in vitro. Cancer Res (1978) 0.86
Stem cell deficiencies and thymic abnormalities in fetal mouse trisomy 16. J Exp Med (1985) 0.85
Down syndrome (trisomy 21) thymuses have a decreased proportion of cells expressing high levels of TCR alpha, beta and CD3. A possible mechanism for diminished T cell function in Down syndrome. Clin Immunol Immunopathol (1990) 0.84
The production of interferon by malignant plasma cells from patients with multiple myeloma. J Immunol (1974) 0.84
Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity. Br J Cancer (1975) 0.83
Staining of preparative 2-D gels. Coomassie blue and imidazole-zinc negative staining. Methods Mol Biol (1999) 0.82
A hypothesis to explain the immune defects in Down syndrome. Prog Clin Biol Res (1995) 0.82
Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor. Immunology (1992) 0.82
Synergistic induction of polypeptides by tumor necrosis factor and interferon-gamma in cells sensitive or resistant to tumor necrosis factor: assessment by computer based analysis of two-dimensional gels using the PDQUEST system. Electrophoresis (1990) 0.82
Characterization of TNF receptors on human thymocytes. Thymus (1996) 0.81
Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes. Am J Med Genet Suppl (1990) 0.80
Overexpression of LFA-1 and ICAM-1 in Down syndrome thymus. Implications for abnormal thymocyte maturation. J Immunol (1993) 0.80
Synthesis of interferon-induced polypeptides in normal and chromosome 21-aneuploid human fibroblasts: relationship to relative sensitivities in antiviral assays. J Interferon Res (1980) 0.79
Studies on mouse Moloney virus induced tumours: II. Detection of p30 in the serum of mice with Moloney leukaemia by in vitro blocking of complement dependent antibody mediated cytotoxicity. Br J Cancer (1975) 0.79
Interferon redux. Nature (1982) 0.79
A micromethod for preparation of human macrophage cultures for the study of lymphocyte-macrophage interaction in immune interferon production and blastogenesis. Immunopharmacology (1978) 0.79
Assignment of the genes for sensitivity to interferon [IfRec] and soluble superoxide dismutase [SOD-1] to mouse chromosome. Ann N Y Acad Sci (1980) 0.78
Transfer factor therapy in ataxia--telangiectasia. Clin Exp Immunol (1977) 0.77
A role for tumor necrosis factor-alpha and interferon-gamma in the regulation of interleukin-4-induced human thymocyte proliferation in vitro. Heightened sensitivity in the Down syndrome (trisomy 21) thymus. Pediatr Res (1992) 0.77
Antisense manganese superoxide dismutase mRNA inhibits the antiviral action of interferon-gamma and interferon-alpha. J Interferon Cytokine Res (1996) 0.76
Abnormalities in the interferon response and immune systems in Down syndrome: studies in human trisomy 21 and mouse trisomy 16. Prog Clin Biol Res (1987) 0.76
The role of superoxide anions in the establishment of an interferon-alpha-mediated antiviral state. Free Radic Res Commun (1992) 0.75
Induction and production of human immune interferon by mitogen- and antigen-stimulated purified lymphocytes cultured in the presence of macrophages. Methods Enzymol (1981) 0.75
Running preparative carrier ampholyte and immobilized pH gradient IEF gels for 2-D. Methods Mol Biol (1999) 0.75
Methods for the characterization of murine lymphocyte population required for the production of interferon. Methods Enzymol (1981) 0.75
Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture. Cancer Chemother Pharmacol (1981) 0.75
Identification of constitutive and gamma-interferon- and interleukin 4-regulated proteins in the human renal carcinoma cell line ACHN. Cancer Res (1997) 0.75
Mechanisms for biphasic or persistent immunologic reactions induced by platelet-activating factor. Prog Clin Biol Res (1989) 0.75
The immunoregulatory importance of interferons in vivo. Ann Inst Pasteur Immunol (1985) 0.75
Polypeptide induction by recombinant human IFN-gamma. Nat Immun Cell Growth Regul (1984) 0.75
A structural analysis of hepatomegaly induced by a hormone-secreting tumor. Exp Mol Pathol (1967) 0.75
Genetic control of the response to interferon. Tex Rep Biol Med (1983) 0.75
In vitro evaluation of 6-thioguanine and alpha-interferon as a therapeutic combination in HL-60 and natural killer cells. Cancer Res (1989) 0.75
Computer-assisted analysis demonstrates that polypeptides induced by natural and recombinant human interferon-alpha are the same and that some have related primary structures. Antiviral Res (1983) 0.75
Synthesis of platelet-activating factor by human monocytes stimulated by platelet-activating factor. J Allergy Clin Immunol (1991) 0.75
Decreased T cell receptor and CD3 expression by Down syndrome thymocytes: evidence for delayed maturation. Prog Clin Biol Res (1990) 0.75
Further experience in testing the sensitivity of human ovarian carcinoma cells to interferon in an in vitro semisolid agar culture system: comparison of solid and ascitic forms of the tumor. Prog Clin Biol Res (1980) 0.75
Interferon as a model lymphokine. Fed Proc (1981) 0.75
Absence of functional and structural homology of natural and recombinant human leukocyte interferon (IFN-alpha) with human alpha-ACTH and beta-endorphin. Biochem Biophys Res Commun (1982) 0.75